230 related articles for article (PubMed ID: 24164543)
1. Soluble receptor for advanced glycation end products predicts 28-day mortality in critically ill patients with sepsis.
Brodska H; Malickova K; Valenta J; Fabio A; Drabek T
Scand J Clin Lab Invest; 2013 Dec; 73(8):650-60. PubMed ID: 24164543
[TBL] [Abstract][Full Text] [Related]
2. Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality.
Cheng Y; Zhong J; Xiang Y; Zeng F; Cai D; Zhao L
Clin Interv Aging; 2014; 9():1981-6. PubMed ID: 25429209
[TBL] [Abstract][Full Text] [Related]
3. Plasma sRAGE Acts as a Genetically Regulated Causal Intermediate in Sepsis-associated Acute Respiratory Distress Syndrome.
Jones TK; Feng R; Kerchberger VE; Reilly JP; Anderson BJ; Shashaty MGS; Wang F; Dunn TG; Riley TR; Abbott J; Ittner CAG; Christiani DC; Mikacenic C; Wurfel MM; Ware LB; Calfee CS; Matthay MA; Christie JD; Meyer NJ
Am J Respir Crit Care Med; 2020 Jan; 201(1):47-56. PubMed ID: 31487195
[No Abstract] [Full Text] [Related]
4. Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients.
Jabaudon M; Futier E; Roszyk L; Chalus E; Guerin R; Petit A; Mrozek S; Perbet S; Cayot-Constantin S; Chartier C; Sapin V; Bazin JE; Constantin JM
Crit Care Med; 2011 Mar; 39(3):480-8. PubMed ID: 21220996
[TBL] [Abstract][Full Text] [Related]
5. Plasma sRAGE is independently associated with increased mortality in ARDS: a meta-analysis of individual patient data.
Jabaudon M; Blondonnet R; Pereira B; Cartin-Ceba R; Lichtenstern C; Mauri T; Determann RM; Drabek T; Hubmayr RD; Gajic O; Uhle F; Coppadoro A; Pesenti A; Schultz MJ; Ranieri MV; Brodska H; Mrozek S; Sapin V; Matthay MA; Constantin JM; Calfee CS
Intensive Care Med; 2018 Sep; 44(9):1388-1399. PubMed ID: 30051136
[TBL] [Abstract][Full Text] [Related]
6. Does an increase in serum FGF21 level predict 28-day mortality of critical patients with sepsis and ARDS?
Li X; Shen H; Zhou T; Cao X; Chen Y; Liang Y; Lu T; He J; Dou Z; Liu C; Tang Y; Zhu Z
Respir Res; 2021 Jun; 22(1):182. PubMed ID: 34154595
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin and N-Terminal Pro-B-Type Natriuretic Peptide for Prognosis in Septic Acute Kidney Injury Patients Receiving Renal Replacement Therapy.
Sheng X; Yang J; Yu G; Fei Y; Bao H; Yin J; Huang W; Tian Z; Wang N; Ronco C
Blood Purif; 2019; 48(3):262-271. PubMed ID: 31311006
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic value of presepsin vs. established biomarkers in critically ill patients with sepsis or systemic inflammatory response syndrome.
Brodska H; Valenta J; Pelinkova K; Stach Z; Sachl R; Balik M; Zima T; Drabek T
Clin Chem Lab Med; 2018 Mar; 56(4):658-668. PubMed ID: 29176018
[TBL] [Abstract][Full Text] [Related]
9. The different roles for the advanced glycation end products axis in heart failure and acute coronary syndrome settings.
Paradela-Dobarro B; Agra RM; Álvarez L; Varela-Román A; García-Acuña JM; González-Juanatey JR; Álvarez E; García-Seara FJ
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1050-1060. PubMed ID: 31371263
[TBL] [Abstract][Full Text] [Related]
10. Changes in circulating procalcitonin versus C-reactive protein in predicting evolution of infectious disease in febrile, critically ill patients.
Hoeboer SH; Groeneveld AB
PLoS One; 2013; 8(6):e65564. PubMed ID: 23762396
[TBL] [Abstract][Full Text] [Related]
11. [The prognostic value of serum procalcitonin on severity of illness in non-sepsis critically ill patients].
Ma J; Wang S; Chen D; Duan J; Li C; Li G
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Aug; 28(8):688-93. PubMed ID: 27434557
[TBL] [Abstract][Full Text] [Related]
12. The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study.
Meertens JH; Nienhuis HL; Lefrandt JD; Schalkwijk CG; Nyyssönen K; Ligtenberg JJ; Smit AJ; Zijlstra JG; Mulder DJ
PLoS One; 2016; 11(8):e0160893. PubMed ID: 27529340
[TBL] [Abstract][Full Text] [Related]
13. Circulating markers of endothelial and alveolar epithelial dysfunction are associated with mortality in pediatric acute respiratory distress syndrome.
Yehya N; Thomas NJ; Meyer NJ; Christie JD; Berg RA; Margulies SS
Intensive Care Med; 2016 Jul; 42(7):1137-45. PubMed ID: 27101828
[TBL] [Abstract][Full Text] [Related]
14. [Significance of combined application of biomarkers in the diagnosis and prognosis assessment of patients with acute respiratory distress syndrome].
Gao Y; Li J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jan; 33(1):69-73. PubMed ID: 33565404
[TBL] [Abstract][Full Text] [Related]
15. Cell Free DNA and Procalcitonin as Early Markers of Complications in ICU Patients with Multiple Trauma and Major Surgery.
Ahmed AI; Soliman RA; Samir S
Clin Lab; 2016 Dec; 62(12):2395-2404. PubMed ID: 28164563
[TBL] [Abstract][Full Text] [Related]
16. The value of circulating long non-coding RNA maternally expressed gene 3 as a predictor of higher acute respiratory distress syndrome risk and 28-day mortality in sepsis patients.
Wu X; Chen D; Yu L
J Clin Lab Anal; 2020 Nov; 34(11):e23488. PubMed ID: 32844492
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of soluble receptor for advanced glycation end products in patients with acute respiratory distress syndrome.
Gu W; Xu Z; Qi F; Sang Z; Wang C; Li F
Int J Clin Exp Med; 2014; 7(12):5558-62. PubMed ID: 25664071
[TBL] [Abstract][Full Text] [Related]
18. Endocan is useful biomarker of survival and severity in sepsis.
Mihajlovic DM; Lendak DF; Brkic SV; Draskovic BG; Mitic GP; Novakov Mikic AS; Cebovic TN
Microvasc Res; 2014 May; 93():92-7. PubMed ID: 24769132
[TBL] [Abstract][Full Text] [Related]
19. The impact of polytrauma on sRAGE levels: evidence and statistical analysis of temporal variations.
Negrin LL; Ristl R; Halat G; Heinz T; Hajdu S
World J Emerg Surg; 2019; 14():13. PubMed ID: 30923559
[TBL] [Abstract][Full Text] [Related]
20. Effect of S100A12 and soluble receptor for advanced glycation end products on the occurrence of severe acute pancreatitis.
Zhao B; Chen Y; Sun WW; Chen WW; Ma L; Yang ZT; Huang J; Chen EZ; Fei J; Mao EQ
J Dig Dis; 2016 Jul; 17(7):475-82. PubMed ID: 27251034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
